SEARCH

SEARCH BY CITATION

References

  • 1
    Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 7685, 1983
  • 2
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488498, 1992
  • 3
    Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E: Wegener's granulomatosis with renal involvement: patient survival and correlation between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 35: 139147, 1991
  • 4
    Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK: Relapse in Wegener's granulomatosis. BMJ 281: 836838, 1980
  • 5
    Reza MJ, Dornfeld M, Goldberg LS, Bluestone R, Pearson CM: Wegener's granulomatosis: long-term followup of patients treated with cyclophosphamide. Arthritis Rheum 18: 501506, 1975
  • 6
    Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon PA: Relapses in patients with systemic vasculitis. QJM 86: 779789, 1993
  • 7
    Reinhold-Keller E, de Groot K, Rudert H, Nölle B, Heller M, Gross WL: Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. QJM 89: 1523, 1996
  • 8
    Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM: Prevention of relapses in Wegener's granulomatosis by treatment with trimethoprim/sulfamethoxazole: a multicenter placebo controlled trial in 81 patients (abstract). Clin Exp Immunol 101: 44, 1995
  • 9
    Handrock K, Reinhold-Keller E, Heller M, Duncker G, Rudert H, Gross WL: Beneficial effects of low-dose methotrexate in Wegener's granulomatosis (abstract). Arthritis Rheum 37 (Suppl 9): S353, 1994
  • 10
    Hoffman GS, Leavitt RY, Kerr GS, Fauci AS: The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35: 13221329, 1992
  • 11
    Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS: An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 38: 608613, 1995
  • 12
    Gross WL: New concepts in Wegener's granulomatosis. In, The Vasculitides. Edited by BMAnsell, PABacon, JTLie, HYazici. London, Chapman and Hall, 1996
  • 13
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lee JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 11011107, 1990
  • 14
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 37: 187192, 1994
  • 15
    Asmuss R, Muhle C, Koltze H, Spielmann RP, Gross WL, Duncker G, Nölle B, Beigel A: Magnetresonanztomographische Kennzeichen der Wegenerschen Granulomatose im Kopfbereich. Fortschr Röntgenstr 157: 1114, 1992
  • 16
    DeRemee RA, McDonald TJ, Harrison G, Coles DT: Wegener's granulomatosis: anatomic correlates, a proposed classification. Mayo Clin Proc 51: 777781, 1976
  • 17
    Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 111: 2840, 1989
  • 18
    Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 37: 919924, 1994
  • 19
    Cohen Tervaert CW, van der Molen L, Sluiter WJ, Stegemann CA, Kallenberg CGM: A comparison of three different disease activity scores in patients with different forms of vasculitides (abstract). Clin Exp Immunol 101: 32, 1995
  • 20
    Hauschild S, Schmitt WH, Csernok E, Flesch B, Rautmann A, Gross WL: ANCA in systemic vasculitides, collagen vascular disease, rheumatic disorders and inflammatory bowel diseases. In, ANCA-Associated Vasculitides: Immunological and Clinical Aspects. Edited by WLGross. New York, Plenum Press, 1993
  • 21
    Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL: Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: association with disease activity. Arthritis Rheum 35: 10881096, 1992
  • 22
    Walton EW: Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). BMJ 256: 973978, 1958
  • 23
    Körber H, Iven H, Gross WL: Bioavailability and pharmacokinetics of methotrexate and its metabolite 7-hydroxy-MTX (7-OH-MTX) after low-dose MTX (25 mg) in patients with chronic rheumatic diseases (abstract). Arthritis Rheum 35 (Suppl 9): S142, 1992
  • 24
    Rasmussen N, Jayne DRW, Abramowicz D, Andrassy K, Bacon PA, Cohen Tervaert JW, Dadonlené J, Feighery C, van Es LA, Ferrario FGG, Gregorini G, de Groot K, Gross WL, Grönhagen-Riska C, Guillevin LCHE, Heigl ZJH, Kallenberg CGM, Landais P, Leshavre P, Lockwood CM, Luqmani R, Mirapeix E, Petterson E, Pusey C, Savage COS, Sinico RA, Specks U, Tzioufas AG, Westman KWA, Wiik A, van der Woude F: European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 101: 2934, 1995
  • 25
    Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671678, 1994
  • 26
    Stegeman AC, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 120: 1217, 1994
  • 27
    Schnabel A, Reinhold-Keller E, Willmann V, Gross WL: Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis. Rheumatol Int 14: 3338, 1994
  • 28
    Krall PL, Mazanec DJ, Wilke WS: Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleve Clin J Med 56: 253257, 1989
  • 29
    Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37: 578582, 1994
  • 30
    Stegeman GA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM: Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 91: 415420, 1993
  • 31
    Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CGM: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336: 709711, 1990
  • 32
    Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS: Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36: 365371, 1993